Liver-Directed Therapy in Neuroendocrine Neoplasms Metastatic to Both Liver and Bone

Liver-Directed Therapy in Neuroendocrine Neoplasms Metastatic to Both Liver and Bone

Bone metastases from gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) have been associated with poor prognosis, but it is unclear whether patients with concurrent bone metastases who receive liver-directed therapy (LDT) would derive survival benefit. The California Cancer Registry dataset,...

Full description

Bibliographic Details
Main Authors: Kristen E. Limbach, Kelly M. Mahuron, Aaron T. Scott, Philip H. G. Ituarte, Gagandeep Singh
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Clinical Medicine
Subjects:
neuroendocrine tumors
liver-directed therapy
bone metastasis
Online Access:https://www.mdpi.com/2077-0383/12/24/7646

Similar Items

Similar Items